title: Interleukin-8 production via protease-activated receptor 2 in human esophageal epithelial cells.
abstract: Interaction between proteases and protease-activated receptor (PAR) 2 has been proposed to mediate inflammatory and immune response in the gastrointestinal tract. Recently, increase in interleukin (IL)-8 in the esophageal mucosa has been associated with the pathogenesis of esophagitis induced by reflux of gastric acids, bile acids or trypsin. The aims of the present study were to determine PAR2 expression in normal human esophageal epithelial cells (HEEC) and to evaluate the mediation of IL-8 production by trypsin-PAR2 interaction in HEEC. Reverse transcription polymerase chain reaction (RT-PCR) and Western blot analysis revealed that PAR2 mRNA and protein were constitutively expressed in HEEC without upregulation by the stimulation with tumor necrosis factor alpha or trypsin. IL-8 was produced in a dose-dependent fashion when cells were stimulated with a PAR2 agonist such as trypsin or SLIGKV-amide. Blocking antibody to PAR2, camostat mesilate (a trypsin inhibitor), p-38 mitogen-activated protein kinase (MAPK) inhibitors or ERK1/2 inhibitors reduced IL-8 production from trypsin-stimulated HEEC. Mutation of the NFkappaB-, AP-1- and NF-IL-6-binding site on the IL-8 gene promoter abrogated the induction of luciferase activities stimulated with trypsin by 100, 80 and 50%, respectively. These results indicate that PAR2 activation in HEEC by trypsin induces NFkappaB- and AP-1-dependent IL-8 production in association with activation of p38 MAPK and ERK1/2, suggesting that esophageal inflammation may be induced by PAR2 activation via reflux of trypsin.
authors.affiliation: Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, Japan. nyoshida@koto.kpu-m.ac.jp
authors.forename: N
authors.initials: N
authors.lastname: Yoshida
authors.forename: K
authors.initials: K
authors.lastname: Katada
authors.forename: O
authors.initials: O
authors.lastname: Handa
authors.forename: T
authors.initials: T
authors.lastname: Takagi
authors.forename: S
authors.initials: S
authors.lastname: Kokura
authors.forename: Y
authors.initials: Y
authors.lastname: Naito
authors.forename: N
authors.initials: N
authors.lastname: Mukaida
authors.forename: T
authors.initials: T
authors.lastname: Soma
authors.forename: Y
authors.initials: Y
authors.lastname: Shimada
authors.forename: T
authors.initials: T
authors.lastname: Yoshikawa
authors.forename: T
authors.initials: T
authors.lastname: Okanoue
mesh_terms: D000906:Antibodies / Q000276:immunology; D002460:Cell Line; D004847:Epithelial Cells / Q000378:metabolism*; D004947:Esophagus / Q000378:metabolism*; D017930:Genes, Reporter / Q000235:genetics; D006801:Humans; D016209:Interleukin-8 / Q000096:biosynthesis*; D020928:Mitogen-Activated Protein Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism; D047428:Protein Kinase Inhibitors / Q000494:pharmacology; D044464:Receptor, PAR-2 / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D014357:Trypsin / Q000378:metabolism
chemical_list: D000906:Antibodies; D016209:Interleukin-8; D047428:Protein Kinase Inhibitors; D044464:Receptor, PAR-2; D020928:Mitogen-Activated Protein Kinases; D014357:Trypsin